Skip to content

Efficacy of platelet rich plasma in treatment of knee osteoarthritis:A single group pre & post intervention study

Efficacy of Platelet Rich Plasma in treatment of knee osteoarthritis: A single group Pre & Post intervention QUASI Experimental study. - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063715
Enrollment
80
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: platelet rich plasma: pre and post intervention analysis after infiltration of platelet rich plasma in knee joint Intervention2: Platelet rich plasma: Under all aseptic precautions PRP

Sponsors

JLN Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 45-65 years with either side OA knees (ASA class I and II) of either gender History of pain in last month Those with imaging findings (X-ray) of degenerative changes of the joint without significant deformity (diagnosed by KL classification ( Grade 2 and 3)

Exclusion criteria

Exclusion criteria: Patients with KL grading I ( doubtful disease) and grade 4 (Severe disease) Patient with history of diabetes mellitus On Immunosuppressive drugs Collagen vascular disorders Cancer or malignant disorders Active infection/ wound of knee Patients with autoimmune and platelet disorders Treatment with anticoagulant and antiplatelet medications within 10 days before injection Use of NSAIDs within 2 days before injection or unwilling to stop then post injection except paracetamol History of knee articular injection of corticosteroid during previous 3 months or use of systemic corticosteroids 2 weeks before PRP injection Patients with genu valgum/Varum greater than 20 degrees Human immunocompromised virus, Hepatitis B virus, Hepatitis C virus, venereal Disease Research Laboratory virus positive cases Knee surgery on affected side within last 12 months Systemic or inflammatory knee disease Presence of warm and tense joint effusion High chances of loss of follow-up History of trauma to affected knee

Design outcomes

Primary

MeasureTime frame
pain will be assessed by WOMEC score and Visual Analogue ScoreTimepoint: Patients will be evaluated on 6 week, 3 months and 6 months after the first injection by a blinded observer for change in WOMAC score

Secondary

MeasureTime frame
VAS scoreTimepoint: at baseline/ 6 week / 3 month and 6 months

Countries

India

Contacts

Public ContactDr Veena Mathur

JLN Medical College Ajmer

veenamathur41@gmail.com9460517947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026